More alcohol consumption increases risk of liver cancer, but coffee is protective
the ONA take:
The amount of alcohol a person has to drink to risk developing liver cancer has been narrowed down. However, drinking coffee appears to protect people from developing the disease.
These findings are from research detailed by the American Institute for Cancer Research (AICR) and the World Cancer Research Fund.
Other risks the researchers identified were obesity and consuming food with aflatoxins, fungal poisons, including cereal, spices, peanuts, and chillies.
The researchers analyzed 34 studies involving 8.2 million people and more than 24,500 cases of liver cancer. This is the first report to quantify alcohol consumption that would raise the risk for liver cancer: just three alcoholic drinks a day.
Two alcoholic drinks a day is not much safer as this increases the risks of other cancers such as breast and esophageal cancer.
This is the first research to produce clear links between increased risk of liver cancer by obesity and number of alcoholic drinks and decreased risk of the disease by coffee consumption. The report adds to the evidence on the impact of obesity on cancer risks.
According to the AICR, if all Americans maintained a healthy weight and avoided alcohol, the US burden of liver cancer would be reduced by 30%.
The amount of alcohol a person has to drink to risk developing liver cancer has been narrowed down.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|